These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 5471517)

  • 81. [Antithrombin and antiplasmin effect of 4-amidinophenylpyruvic acid in vivo].
    Markwardt F; Klöcking HP; Nowak G
    Thromb Diath Haemorrh; 1970 Oct; 24(1):240-7. PubMed ID: 5483964
    [No Abstract]   [Full Text] [Related]  

  • 82. [Antifibrinolytic and toxic properties of 5-aminocaproic acid under experimental conditions].
    Zaĭtseva RI
    Farmakol Toksikol; 1965; 28(2):196-9. PubMed ID: 5849201
    [No Abstract]   [Full Text] [Related]  

  • 83. [On the influence of protease inhibitors and synthetic antifibrinolytic agents on the bleeding time].
    Vogel G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):174-8. PubMed ID: 4174655
    [No Abstract]   [Full Text] [Related]  

  • 84. [Localized fibrinolysis of the tonsil and antiplasmin compounds].
    Asaga M; Okamoto M; Asaga H; Kimura M
    Nihon Jibiinkoka Gakkai Kaiho; 1971 Feb; 74(2):462-3. PubMed ID: 5106660
    [No Abstract]   [Full Text] [Related]  

  • 85. [The fibrinolytic activity of the endometrium and myometrium, decidua and placenta and cervical and corpus carcinomas. Physiology, pathology and clinico-therapeutic consequences].
    Schmidt-Matthiesen H
    Bibl Gynaecol; 1967; 44():1-117. PubMed ID: 5302142
    [No Abstract]   [Full Text] [Related]  

  • 86. [On the physiology of blood coagulation and fibrinolysis as the basic principles in the clinical use of anticoagulants, thrombolytics and inhibitors of fibrinolysis].
    Van de Loo J
    Rev Colomb Obstet Ginecol; 1967; 18(5):321-6. PubMed ID: 5612568
    [No Abstract]   [Full Text] [Related]  

  • 87. Treatment of subarachnoid hemorrhage: the ability of epsilon aminocaproic acid to cross the blood brain barrier and reduce the spinal fluid fibrinolytic activity.
    Levy BJ; Silver D
    Surg Forum; 1968; 19():413-4. PubMed ID: 5718686
    [No Abstract]   [Full Text] [Related]  

  • 88. Fibrinolysis.
    Fearnley GR
    Adv Drug Res; 1973; 7():107-63. PubMed ID: 4280240
    [No Abstract]   [Full Text] [Related]  

  • 89. [The development of fibrinolysis inhibitors].
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):5-14. PubMed ID: 4173881
    [No Abstract]   [Full Text] [Related]  

  • 90. Fibrinolytic system in hypotensive patients; with a special reference to the effect of epsilon-amino caproic acid (EACA).
    Gabryelewicz A; Niewiarowski S; Prokopowicz J; Worowski K
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):433-8. PubMed ID: 4232163
    [No Abstract]   [Full Text] [Related]  

  • 91. [Inveestigation of the inhibition of fibrinolysis using epsilon-aminocapronic acid].
    Stenszky E; Aszódi L; Hatvani I
    Acta Pharm Hung; 1968 Jun; 38(2):191-6. PubMed ID: 5723266
    [No Abstract]   [Full Text] [Related]  

  • 92. The effect of epsilon-amino-caproic acid, acetyl-epsilon-amino-caproic acid and trasylol on allergic reactions induced by dinitrochlorobenzen in guinea pigs.
    Onisk Z; Tchórzewski H
    Pol Med J; 1968; 7(1):190-5. PubMed ID: 5300915
    [No Abstract]   [Full Text] [Related]  

  • 93. [Fibrinolytic problems in obstetrics].
    Doichinov A; Glavanakova V
    Akush Ginekol (Sofiia); 1967; 6(3):218-28. PubMed ID: 4880476
    [No Abstract]   [Full Text] [Related]  

  • 94. [Triggering of massive thrombus formation with epsilon-aminocaproic acid after previous activation of the coagulation system].
    Herschlein HJ; Steichele DF
    Thromb Diath Haemorrh; 1967 May; 17(3-4):568-77. PubMed ID: 5589304
    [No Abstract]   [Full Text] [Related]  

  • 95. [Fibrinolytic hemorrhages and their treatment by p-aminomethylbenzoic acid].
    Sundermann A
    Verh Dtsch Ges Inn Med; 1965; 71():749-53. PubMed ID: 5298271
    [No Abstract]   [Full Text] [Related]  

  • 96. [On the aspects of the hemostatic action of epsilon-aminocaproic acid].
    Barkagan ZS; Bur'ianov IaB; Kompaneets EIu; Lapa VA; Eremin GF; Mitel'man LSh; Shevchenko VI; Shlotgauér NR
    Probl Gematol Pereliv Krovi; 1965 Aug; 10(8):20-6. PubMed ID: 5868998
    [No Abstract]   [Full Text] [Related]  

  • 97. [Influence of fibrinolysis inhibitors on anticoagulant induced hemorrhages].
    Vogel G; Klöcking HP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 99(4):367-75. PubMed ID: 4127132
    [No Abstract]   [Full Text] [Related]  

  • 98. [Research on the pathogenetic mechanisms of hemorrhages due to induced venous stasis. II. Role of fibrinolysis in the pathogenesis of the hemorrhagic phenomenon due to stasis].
    Neri Serneri GG; Rossi Ferrini PL; Franchi F; Paoletti P
    Haematologica; 1965; 50(4):251-66. PubMed ID: 4953556
    [No Abstract]   [Full Text] [Related]  

  • 99. [Delivery of healthy twins following a successfully treated premature placental detachment occurring at the end of the 6th month. (Case report)].
    Pleissner K
    Z Arztl Fortbild (Jena); 1968 May; 62(9):477-81. PubMed ID: 5697177
    [No Abstract]   [Full Text] [Related]  

  • 100. Lillehei CW: Effect of epsilon aminocaproic acid upon blood loss following open-heart surgery: an analysis of 340 patients.
    Sterns LP
    Can J Surg; 1967 Jul; 10(3):304-7. PubMed ID: 6027393
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.